<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001236.pub2" GROUP_ID="PREG" ID="116099100323363396" MERGED_FROM="" MODIFIED="2014-11-13 10:04:06 +0000" MODIFIED_BY="Leanne Jones" REVIEW_NO="0194" REVMAN_SUB_VERSION="5.3.4 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2014-11-13 10:04:06 +0000" MODIFIED_BY="Leanne Jones">
<TITLE>Routine perineal shaving on admission in labour</TITLE>
<CONTACT MODIFIED="2014-11-13 10:04:06 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="15836" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Vittorio</FIRST_NAME><LAST_NAME>Basevi</LAST_NAME><EMAIL_1>vbasevi@regione.emilia-romagna.it</EMAIL_1><ADDRESS><DEPARTMENT>SaPeRiDoc, Primary health care, general medicine, planning and development of health services</DEPARTMENT><ORGANISATION>Emilia-Romagna Regional health authority</ORGANISATION><CITY>Bologna</CITY><COUNTRY CODE="IT">Italy</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-11-13 10:04:06 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="15836" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Vittorio</FIRST_NAME><LAST_NAME>Basevi</LAST_NAME><EMAIL_1>vbasevi@regione.emilia-romagna.it</EMAIL_1><ADDRESS><DEPARTMENT>SaPeRiDoc, Primary health care, general medicine, planning and development of health services</DEPARTMENT><ORGANISATION>Emilia-Romagna Regional health authority</ORGANISATION><CITY>Bologna</CITY><COUNTRY CODE="IT">Italy</COUNTRY></ADDRESS></PERSON><PERSON ID="15939" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Tina</FIRST_NAME><LAST_NAME>Lavender</LAST_NAME><POSITION>Chair of Midwifery</POSITION><EMAIL_1>tina.lavender@manchester.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>School of Nursing, Midwifery and Social Work</DEPARTMENT><ORGANISATION>The University of Manchester</ORGANISATION><ADDRESS_1>Oxford Road</ADDRESS_1><CITY>Manchester</CITY><ZIP>M13 9PL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 161 3060260</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-11-12 09:35:03 +0000" MODIFIED_BY="Sonja L Henderson">
<UP_TO_DATE>
<DATE DAY="12" MONTH="6" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="12" MONTH="6" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="12" MONTH="6" YEAR="2016"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="11" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-10-23 11:17:03 +0100" MODIFIED_BY="Heather Maxwell">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2014-10-23 11:17:03 +0100" MODIFIED_BY="Heather Maxwell">
<DATE DAY="12" MONTH="6" YEAR="2014"/>
<DESCRIPTION>
<P>Search and methods updated. No new trials identified. 'Summary of findings' table incorporated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2014-09-27 10:36:17 +0100" MODIFIED_BY="Sonja L Henderson">
<DATE DAY="12" MONTH="6" YEAR="2014"/>
<DESCRIPTION>
<P>Review updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-06-06 12:28:49 +0100" MODIFIED_BY="Leanne V Jones">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-06-06 12:28:49 +0100" MODIFIED_BY="Leanne V Jones">
<DATE DAY="13" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-02-13 16:31:41 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Search updated and one new trial identified. The conclusions have not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-13 16:31:44 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="1" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-01-02 16:50:38 +0000" MODIFIED_BY="Sonja L  Henderson">
<DATE DAY="17" MONTH="11" YEAR="2003"/>
<DESCRIPTION>
<P>Updated search. No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2014-11-13 09:58:02 +0000" MODIFIED_BY="Leanne V Jones">
<INTERNAL_SOURCES MODIFIED="2014-11-13 09:58:02 +0000" MODIFIED_BY="Leanne V Jones">
<SOURCE MODIFIED="2014-09-08 11:37:52 +0100" MODIFIED_BY="[Empty name]">
<NAME>Direzione generale sanità e politiche sociali,Regione Emilia-Romagna,Bologna</NAME>
<COUNTRY CODE="IT">Italy</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2014-09-27 11:30:43 +0100" MODIFIED_BY="Sonja L Henderson">
<SOURCE MODIFIED="2014-09-27 11:30:43 +0100" MODIFIED_BY="Sonja L Henderson">
<NAME>UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-11-12 09:36:46 +0000" MODIFIED_BY="Sonja L Henderson">
<SUMMARY MODIFIED="2014-11-11 06:57:11 +0000" MODIFIED_BY="Heather Maxwell">
<TITLE MODIFIED="2008-01-28 11:29:21 +0000" MODIFIED_BY="Sonja L  Henderson">Routinely shaving women in the area around the vagina on admission to hospital in labour</TITLE>
<SUMMARY_BODY MODIFIED="2014-11-11 06:57:11 +0000" MODIFIED_BY="Heather Maxwell">
<P>Women may have their pubic hairs shaved with a razor (perineal shaving) when they are admitted to hospital to give childbirth. This is done in the belief that shaving reduces the risk of infection if the perineum tears or a episiotomy is performed and that it makes suturing easier and helps with instrumental deliveries. Shaving is a routine procedure in some countries. Three controlled trials that involved a total of 1039 women were reported on between 1922 and 2005. They each used an antiseptic skin preparation and compared perineal shaving with cutting vulval hairs. The overall quality of evidence ranged from very low (for the outcomes postpartum maternal febrile morbidity and neonatal infection) to low (for the outcomes wound infection and maternal satisfaction). When the findings of the trials were combined, no differences were found, with and without shaving, on the number of mothers who experiencing high body temperatures after the birth. One trial also looked at perineal wound infection, the incidence of open wounds and maternal satisfaction immediately after a perineal repair had been completed and found no difference between groups. Most of the side-effects attributable to shaving occurred later, as described by one of the trials. These included irritation, redness, multiple superficial scratches from the razor and burning and itching of the vulva. One trial assessed maternal satisfaction and found no difference between groups. Other outcomes such as pain, embarrassment or discomfort during hair regrowth, were not reported. The present review found no evidence of any clinical benefit with perineal shaving. Not routinely shaving women before labour appeared safe.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-11-12 09:36:46 +0000" MODIFIED_BY="Sonja L Henderson">
<ABS_BACKGROUND>
<P>Pubic or perineal shaving is a procedure performed before birth in order to lessen the risk of infection if there is a spontaneous perineal tear or if an episiotomy is performed.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effects of routine perineal shaving before birth on maternal and neonatal outcomes, according to the best available evidence.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2014-06-16 00:06:46 +0100" MODIFIED_BY="Lynn Hampaon">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (12 June 2014).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All controlled trials (including quasi-randomised) that compare perineal shaving versus no perineal shaving.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2014-09-21 07:29:51 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed all potential studies for inclusion, assessed risk of bias and extracted the data using a predesigned form. Data were checked for accuracy.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-11-12 09:36:46 +0000" MODIFIED_BY="Sonja L Henderson">
<P>Three randomised controlled trials (1039 women) published between 1922 and 2005 fulfilled the prespecified criteria. In the earliest trial, 389 women were alternately allocated to receive either skin preparation and perineal shaving or clipping of vulval hair only. In the second trial, which included 150 participants, perineal shaving was compared with the cutting of long hairs for procedures only. In the third and most recent trial, 500 women were randomly allocated to shaving of perineal area or cutting of perineal hair. The primary outcome for all three trials was maternal febrile morbidity; no differences were found (risk ratio (RR) 1.14, 95% confidence interval (CI) 0.73 to 1.76). No differences were found in terms of perineal wound infection (RR 1.47, 95% CI 0.80 to 2.70) and perineal wound dehiscence (RR 0.33, 95% CI 0.01 to 8.00) in the most recent trial involving 500 women, which was the only trial to assess these outcomes. In the smallest trial, fewer women who had not been shaved had Gram-negative bacterial colonisation compared with women who had been shaved (RR 0.83, 95% CI 0.70 to 0.98). There were no instances of neonatal infection in either group in the one trial that reported this outcome. There were no differences in maternal satisfaction between groups in the larger trial reporting this outcome (mean difference (MD) 0.00, 95% CI -0.13 to 0.13). No trial reported on perineal trauma. One trial reported on side-effects and these included irritation, redness, burning and itching.</P>
<P>The overall quality of evidence ranged from very low (for the outcomes postpartum maternal febrile morbidity and neonatal infection) to low (for the outcome maternal satisfaction and wound infection).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There is insufficient evidence to recommend perineal shaving for women on admission in labour.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-11-11 06:57:50 +0000" MODIFIED_BY="Heather Maxwell">
<BACKGROUND MODIFIED="2014-10-24 13:10:17 +0100" MODIFIED_BY="Heather Maxwell">
<CONDITION MODIFIED="2014-09-12 11:46:19 +0100" MODIFIED_BY="[Empty name]">
<P>Childbirth preparation has traditionally included the practice of routine pubic hair removal, in the belief that this will lessen the risk of infection that could be caused by spontaneous perineal tear or episiotomy. It has also been suggested that perineal shaving is likely to make suturing easier and safer (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2014-09-12 11:47:14 +0100" MODIFIED_BY="[Empty name]">
<P>Pubic or external genitals hair removal with a razor is also known as perineal shaving. This procedure is performed before childbirth in an attempt to reduce maternal and/or neonatal morbidity.</P>
</INTERVENTION>
<THEORY MODIFIED="2014-09-12 11:47:55 +0100" MODIFIED_BY="[Empty name]">
<P>A hairless site may increase the ease in which perineal trauma is sutured, as this may enable better access and clearer observation of the wound. However, using a razor to shave the perineum can create cutaneous microlacerations that may lead to colonisation with micro-organisms (<LINK REF="REF-Briggs-1997" TYPE="REFERENCE">Briggs 1997</LINK>). Furthermore, perineal shaving may be disliked by the woman (<LINK REF="REF-Oakley-1979" TYPE="REFERENCE">Oakley 1979</LINK>), may cause discomfort during the period of hair regrowth (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>) and may cause maternal embarrassment (<LINK REF="REF-Romney-1980" TYPE="REFERENCE">Romney 1980</LINK>). A study investigated the prevalence and correlates of complications related to pubic hair removal in a diverse clinical sample of women attending a public clinic (<LINK REF="REF-DeMaria-2014" TYPE="REFERENCE">DeMaria 2014</LINK>). In this sample, 60% experienced at least one health complication because of the removal, of which the most common were epidermal abrasion and ingrown hairs.</P>
</THEORY>
<IMPORTANCE MODIFIED="2014-10-24 13:10:17 +0100" MODIFIED_BY="Heather Maxwell">
<P>Six randomised controlled trials (972 participants) were systematically reviewed for preoperative hair removal to reduce surgical site infection in the general population (<LINK REF="REF-Tanner-2011" TYPE="REFERENCE">Tanner 2011</LINK>). Two of the studies had three comparison arms that compared hair removal (shaving, clipping, or depilatory cream) with no hair removal. No statistically significant difference was found in surgical site infections between trial arms, within these studies. Furthermore, the studies were underpowered to compare infection rates. A further three trials (1343 participants) that compared shaving with clipping showed significance in surgical site infections associated with shaving (risk ratio (RR) 2.09, 95% confidence interval (CI) 1.15 to 3.80).</P>
<P>Routine shaving is a procedure that has been discontinued in some countries, but still performed in many other high-, middle- and lower-income countries (<LINK REF="REF-Qian-2001" TYPE="REFERENCE">Qian 2001</LINK>; <LINK REF="REF-Colomar-2004" TYPE="REFERENCE">Colomar 2004</LINK>; <LINK REF="REF-d_x0027_Orsi-2005" TYPE="REFERENCE">d'Orsi 2005</LINK>; <LINK REF="REF-Chen-2006" TYPE="REFERENCE">Chen 2006</LINK>; <LINK REF="REF-Conde_x002d_Agudelo-2008" TYPE="REFERENCE">Conde-Agudelo 2008</LINK>; <LINK REF="REF-Sweidan-2008" TYPE="REFERENCE">Sweidan 2008</LINK>; <LINK REF="REF-Charrier-2010" TYPE="REFERENCE">Charrier 2010</LINK>; <LINK REF="REF-SEA_x002d_ORCHID-2011" TYPE="REFERENCE">SEA-ORCHID 2011</LINK>; <LINK REF="REF-Altaweli-2014" TYPE="REFERENCE">Altaweli 2014</LINK>; <LINK REF="REF-Nagpal-2014" TYPE="REFERENCE">Nagpal 2014</LINK>).</P>
<P>The aim of this review is to identify whether perineal shaving reduces maternal and/or neonatal morbidity when performed on admission in labour.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>The objective of this review is to determine the effects of perineal shaving compared with no shaving prior to birth. The scientific evidence provided by this review will enable purchasers, providers and consumers of health care to decide the most appropriate form of care in terms of both health gain and cost.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-10-24 13:19:15 +0100" MODIFIED_BY="Heather Maxwell">
<SELECTION_CRITERIA MODIFIED="2014-10-24 13:10:30 +0100" MODIFIED_BY="Heather Maxwell">
<CRIT_STUDIES MODIFIED="2014-09-23 14:46:14 +0100" MODIFIED_BY="[Empty name]">
<P>All identified controlled trials (including quasi-randomised) that compare routine perineal shaving with no perineal shaving prior to birth. Cross-over trials and cluster-randomised trials are not eligible for inclusion.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>All primiparous and multiparous women, irrespective of mode of delivery, with or without perineal trauma.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2014-09-23 15:10:18 +0100" MODIFIED_BY="[Empty name]">
<P>All controlled trial comparisons of perineal shaving versus no perineal shaving prior to birth.</P>
<P>Comparisons eligible for inclusion include:</P>
<OL>
<LI>perineal shaving versus no intervention;</LI>
<LI>perineal shaving verus control (e.g. a different method or area of hair removal such as clipping or cutting of pubic/vulval or perineal hair).</LI>
</OL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-10-24 13:10:30 +0100" MODIFIED_BY="Heather Maxwell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-10-24 13:10:30 +0100" MODIFIED_BY="Heather Maxwell">
<OL>
<LI>Postpartum maternal febrile morbidity: clinical signs or symptoms (persistent temperature of at least 37.5 degrees centigrade, tachycardia), and an elevated white blood cell count (at least 20,000/mm³).</LI>
<LI>Wound infection: persistent temperature of at least 37.5 degrees centigrade with clinical symptoms such as localised erythema and/or discharge and/or a positive wound swab culture with an organism likely to cause infection.</LI>
<LI>Neonatal infection: if the baby had one or more of the following: probable sepsis; probable meningitis; or probable pneumonia. This will be considered present if the baby has clinical signs/symptoms (respiratory distress, irritability, temperature instability, feeding difficulties, early onset jaundice, poor perfusion, hypotension, apnoea, seizures, tachycardia, lethargy), and either an abnormal sepsis screen or abnormal cerebrospinal fluid finding.</LI>
</OL>
<P>Poorly defined outcomes were included for information purposes only.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-10-24 13:10:30 +0100" MODIFIED_BY="Heather Maxwell">
<OL>
<LI>Psychological outcomes: level of discomfort, degree of pain, degree of embarrassment and level of maternal satisfaction.</LI>
<LI>Perineal trauma.</LI>
<LI>Wound dehiscence and need for wound resuturing.</LI>
<LI>Side-effects (not pre-specified).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-09-11 10:26:32 +0100" MODIFIED_BY="[Empty name]">
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<ELECTRONIC_SEARCHES MODIFIED="2014-09-11 10:25:39 +0100" MODIFIED_BY="[Empty name]">
<P>We contacted the Trials Search Co-ordinator to search the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register (12 June 2014).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of Embase;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.</P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-10-24 13:19:15 +0100" MODIFIED_BY="Heather Maxwell">
<P>For methods used in the previous update, please see <LINK REF="REF-Basevi-2000" TYPE="REFERENCE">Basevi 2000</LINK>. </P>
<P>For this update, no new studies were identified from the updated search. However, full risk of bias was performed and the quality of the evidence was assessed using the GRADE approach for all of the currently included studies as described below. In future updates, we will use the full methods outlined in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<STUDY_SELECTION MODIFIED="2014-09-27 11:05:56 +0100" MODIFIED_BY="Sonja L Henderson">
<P>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion. </P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-09-27 11:06:28 +0100" MODIFIED_BY="Sonja L Henderson">
<P>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion. We entered data into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and checked for accuracy.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-10-24 13:10:59 +0100" MODIFIED_BY="Heather Maxwell">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) and resolved any disagreements by discussion.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We investigated for each included study the method used to generate the allocation sequence to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We investigated for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes.</P>
<P>We assessed the methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We investigated for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), whether reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We investigated for each included study the possibility of selective outcome reporting bias.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We investigated for each included study any important concerns we have about other possible sources of bias.</P>
<P>We assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <I>Handbook </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings.</P>
<P>For this update the quality of the evidence has been assessed using the GRADE approach (<LINK REF="REF-Schunemann-2009" TYPE="REFERENCE">Schunemann 2009</LINK>) in order to assess the quality of the body of evidence relating to the following key outcomes for the main comparison.</P>
<OL>
<LI>Postpartum maternal febrile morbidity.</LI>
<LI>Neonatal infection.</LI>
<LI>Wound infection.</LI>
<LI>Maternal satisfaction (continuous data).</LI>
</OL>
<P>GRADEprofiler (<LINK REF="REF-GRADE-2008" TYPE="REFERENCE">GRADE 2008</LINK>) has been used to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create &#8217;Summary of findings&#8217; tables. A summary of the intervention effect and a measure of quality for each of the above outcomes has been produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2014-09-21 08:06:08 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we used the mean difference as the outcome taken into account was measured in a single trial.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-09-21 08:06:49 +0100" MODIFIED_BY="[Empty name]">
<P>Cluster-randomised trials and cross-over trials are not eligible for inclusion. </P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-10-24 13:19:15 +0100" MODIFIED_BY="Heather Maxwell">
<P>For two of the included studies, it was not possible to determine levels of attrition. In the next update of this review, if additional trials are included, we will conduct a sensitivity analysis, with poor quality studies with high levels of missing data excluded from the analysis.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-10-24 13:11:25 +0100" MODIFIED_BY="Heather Maxwell">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if the I² was greater than 60% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. 
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-09-11 10:07:37 +0100" MODIFIED_BY="[Empty name]">
<P>In the future updates, If there are 10 or more studies in the meta-analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-10-24 13:11:25 +0100" MODIFIED_BY="Heather Maxwell">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We used fixed-effect meta-analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials&#8217; populations and methods are judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we planned to use random-effects meta-analysis to produce an overall summary if an average treatment effect across trials is considered clinically meaningful. The random-effects summary will be treated as the average of the range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. We did not use random-effects analysis in this update. If we use random-effects analyses in future updates, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-11-07 15:51:51 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY_DESCRIPTION MODIFIED="2014-10-24 13:12:57 +0100" MODIFIED_BY="Heather Maxwell">
<SEARCH_RESULTS MODIFIED="2014-10-24 13:12:57 +0100" MODIFIED_BY="Heather Maxwell">
<P>Three randomised controlled trials involving 1039 women were identified where perineal shaving was compared with no shaving.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-09-21 08:15:59 +0100" MODIFIED_BY="[Empty name]">
<P>In the earliest trial (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>), 389 women were alternately allocated to receive either skin preparation and perineal shaving (control) or clipping of vulval hair only (experimental). This was carried out as part of a larger trial which assessed the potential benefits of the study hospital's admission procedure. The routine skin preparation included scrubbing of external genitalia and inner thighs with soap and water and, if labour was imminent, vulval douching with sterile water, alcohol and a weak solution of bichloride of mercury.<BR/>
<BR/>The second trial (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>), which included 150 women, compared perineal shaving versus the cutting of long hairs for procedures only. Fifty women in each arm received pHisoHex wash as skin preparation and 25 in each arm received povidone-iodine spray.</P>
<P>The third trial (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) included 500 women. In this trial, 42 women were excluded after randomisation due to caesarean section. The trial compared perineal shaving versus cutting of perineal hair, down to 0.5 cm above the skin. In all women the perineal region was scrubbed with 4% chlorhexidine scrub and rinsed with savlon solution (1:100).</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-09-21 08:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>No studies were excluded. </P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-10-24 13:11:58 +0100" MODIFIED_BY="Heather Maxwell">
<P>For some domains the trials lacked adequate descriptions of methods to allow judgements on risk of bias, and so have been classified as unclear.</P>
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> for a summary of 'Risk of bias' assessments.</P>
<ALLOCATION MODIFIED="2014-10-24 13:11:58 +0100" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation</HEADING>
<P>The Johnston trial (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>) assessed perineal shaving in 389 women as part of a larger study (N = 1059), which explored general preparation for childbirth. Women were alternately allocated to experimental or control group. There is no information on the timing of allocation, the personnel involved, or the number of exclusions during this process. We judged this study to be at high risk of selection bias. In the Kantor trial (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>), which includes 150 participants, the method for determining the randomisation sequence was not mentioned; we judged there was insufficient information about the sequence generation process (unclear risk of bias). One study (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) reported having used a published table of random sequence generation (low risk of bias).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment</HEADING>
<P>Neither <LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK> nor <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK> provided sufficient detail about allocation sequence concealment and therefore the quality was difficult to assess. In particular, the method of allocation was unclear and, as such, we considered both these studies to be at high risk of selection bias. In the third trial (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>), 500 women admitted to the labour room were randomly allocated to receive either perineal shaving or perineal hair cutting using a series of sealed sequentially numbered envelopes, therefore we considered this to be at low risk of bias.</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2014-09-27 11:11:17 +0100" MODIFIED_BY="Sonja L Henderson">
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (performance bias)</HEADING>
<P>Because blinding of participants and personnel was not possible due to the nature of the intervention, all the trials present a high risk of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (detection bias)</HEADING>
<P>None of the three included studies described blinding of outcome assessors. Because it is likely that staff evaluating outcomes would be aware of treatment allocation, these studies have been assessed as high risk of bias due to lack of blinding.</P>
</SUBSECTION>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-09-23 14:53:12 +0100" MODIFIED_BY="[Empty name]">
<P>For the Johnston trial (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>) and the Kantor trial (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>), it is not possible to determine the completeness of data including attrition and exclusions from the analysis. We judged these studies to be at unclear risk of bias. The Kovavisarach trial (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) has no missing outcome data and is therefore at low risk of attrition bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2014-09-27 11:11:51 +0100" MODIFIED_BY="Sonja L Henderson">
<P>In two trials (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>; <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>), selective reporting was at unclear risk of bias. In the Kovavisarach trial (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>), we have insufficient information to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217; of reporting bias, but it seems unlikely that not all of the study&#8217;s pre-specified primary outcomes have been reported.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2014-09-27 11:12:28 +0100" MODIFIED_BY="Sonja L Henderson">
<P>In the Kovavisarach trial (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>), there was a statistically significant difference in the mean gestational age between the groups (0.30 week) but, like the authors, we could not determine any clinical relevance of this finding and, therefore, it is not identified as a source of bias.</P>
<P>No study provides information on sources of funding but, given the characteristics of intervention and the direction of results, it seems unlikely that this problem could introduce bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-11-07 15:51:51 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="3">Perineal shaving versus no perineal shaving</HEADING>
<P>Three trials (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>; <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) were identified by the search (1039 women).</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Postpartum maternal febrile morbidity</HEADING>
<P>In the <LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK> trial, the primary outcome was maternal febrile morbidity, defined as temperature 100.4 degrees Fahrenheit or above on two successive days (excluding the day of delivery), and taken every four hours. No significant differences were found between the trial arms (risk ratio (RR) 1.31, 95% confidence interval (CI) 0.74 to 1.80). There was no microbiological evidence to suggest differences in maternal infection between groups.</P>
<P>In the <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK> trial, no significant differences were found between those women who had or had not received a perineal shave with regard to maternal pyrexia during the four days after delivery (RR 0.80, 95% CI 0.22 to 2.86).</P>
<P>In the <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK> trial, no significant differences were found between those women who had or had not received a perineal shave with regard to puerperal morbidity, defined as temperature 38.0 degrees centigrade (100.4 degrees Fahrenheit) or higher, arising on any two of the first 10 days postpartum, exclusive of the first 24 hours; the oral temperature was taken at least four times daily (RR 0.49, 95% CI 0.09 to 2.66).</P>
<P>When the findings of all the trials were combined, no differences were found in those who had or had not been shaved with regard to maternal febrile morbidity (three trials, N = 997; RR 1.14, 95% CI 0.73 to 1.76), <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.</P>
<P>In the Kantor trial (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>), there were no differences in Gram-positive bacteria colonization. A significant difference was found in the number of women who were colonized by Gram-negative bacteria (one trial, N = 150; RR 0.83, 95% CI 0.70 to 0.98) in favour of those who had been shaved, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Wound infection, wound dehiscence and need for wound resuturing</HEADING>
<P>Only the <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK> trial assessed this outcome. No statistically significant differences were found between the trial arms with regard to perineal wound infection, defined as pain and erythema of the surgical margins of perineal or episiotomy wound with or without serous or purulent discharge (one trial, N = 458; RR 1.47, 95% CI 0.80 to 2.70), <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>, and perineal wound dehiscence (one trial, N = 458; RR 0.33, 95% CI 0.01 to 8.00), <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Neonatal infection</HEADING>
<P>Only the <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK> trial assessed this outcome and reported no instances of neonatal infection in either group.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Maternal satisfaction</HEADING>
<P>Only the <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK> trial assessed this outcome. A five-point Likert scale was used to measure a women's intensity of satisfaction (5, excellent; 4, good; 3, average; 2; fair and 1; poor<B>). </B>No significant difference was found between the trial arms (one trial, N = 458; mean difference (MD) 0.00; 95% CI -0.13 to 0.13), <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Perineal trauma</HEADING>
<P>No trial reported this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Side-effects (not pre-specified)</HEADING>
<P>Only the <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK> trial described the side-effects experienced by the women who had been shaved. This included irritation, redness, multiple superficial scratches and burning and itching of the vulva. As the number of side-effects was not reported for women in the unshaved group, this information could not be included in the analysis. The <LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK> and <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK> trials made no reference to any side-effects attributable to shaving.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-11-11 06:57:50 +0000" MODIFIED_BY="Heather Maxwell">
<SUMMARY_OF_RESULTS MODIFIED="2014-10-24 13:19:45 +0100" MODIFIED_BY="Heather Maxwell">
<P>All the trials provided a limited assessment of the effects of perineal shaving. In particular, only one trial (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) assessed neonatal outcomes and maternal satisfaction. No trial assessed the outcomes associated with maternal views such as pain, embarrassment or discomfort. Although a significant difference was found in the number of women who had colonised Gram-negative bacteria in favour of those who had been shaved (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>), when combined with Gram-positive bacteria no differences were found. Moreover, all cases of maternal pyrexia were attributed to other causes, i.e. urinary tract infection and endometritis (<LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>). The most recent and larger trial found no differences between the trial arms on perineal wound infection and dehiscence and puerperal morbidity and infection (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>). No significant differences were found between those women who had or had not received a perineal shave with regard to maternal satisfaction, evaluated immediately after perineal repair had finished (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>). However, the timing of assessment could be unsuitable, because most of the side-effects attributable to shaving are late complications.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2014-08-14 09:29:23 +0100" MODIFIED_BY="Leanne V Jones">
<P>A comprehensive and extensive literature review was performed to identify studies that assessed the benefits and harms of routine perineal shaving before childbirth. The findings can be equally applied to different birth environments, to high-, middle- and lower-income countries, to out-of-hospital settings, or to setting where skilled birth attendants are available and setting where skilled birth attendants are not present.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2014-11-11 06:57:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>Two of the three trials (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>; <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>) identified by the initial search were more than 40 years old which may have accounted for the poor reporting of information. This also meant that personal communication to seek additional information about the trials was not possible. The Johnston trial (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>) was, in fact, the first trial registered in the Cochrane Pregnancy and Childbirth Group's register. The quality of two of the three included studies (<LINK REF="STD-Johnston-1922" TYPE="STUDY">Johnston 1922</LINK>; <LINK REF="STD-Kantor-1965" TYPE="STUDY">Kantor 1965</LINK>) was very low. The main limitations in the quality of these studies were adequate sequence generation and concealment of allocation. The lack of adequate sequence generation and allocation concealment can lead to biased estimates of treatment effects. Due to the features and the modes of intervention, blinding of participants and personnel was impossible. For blinding of outcome assessors, blinding also was absent in all studies. This was considered a high risk of bias because clinicians&#8217; assessment and management could be influenced by knowledge of the treatment group. The quality of the evidence was assessed according to the GRADE approach and is displayed in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. The overall quality of evidence ranged from very low (for the outcomes postpartum maternal febrile morbidity, neonatal infection) to low (for the outcomes maternal satisfaction, wound infection).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-10-24 13:14:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>The Trials Search Co-ordinator searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register (12 June 2014) and we searched reference lists of included trials. In two of the three trials, clarification of information with authors was not possible as the trials were very old. Given that all included studies presented results not favourable to the intervention investigated, it seems unlikely, although not impossible, that we missed unpublished data presented at smaller conferences or studies published in non-English language or in non-indexed journals.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2014-10-24 13:14:28 +0100" MODIFIED_BY="Heather Maxwell">
<P>This review agrees with a systematic review published in 2011 (<LINK REF="REF-Tanner-2011" TYPE="REFERENCE">Tanner 2011</LINK>) that evaluated if routine pre-operative hair removal (compared with no removal) and the method of hair removal (shaving, clipping, or depilatory cream) influence rates of surgical site infections. The systematic review included three trials (1343 participants) that compared shaving with clipping and found significantly more surgical site infections associated with shaving (RR 2.09, 95% CI 1.15 to 3.80). In the same systematic review, six trials (972 participants) compared hair removal (shaving, clipping, or depilatory cream) with no hair removal and showed no statistically significant difference in surgical site infections rates; however, the comparison is underpowered.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2014-09-23 14:58:55 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2014-09-23 14:58:55 +0100" MODIFIED_BY="[Empty name]">
<P>There is insufficient evidence to suggest that perineal shaving confers any benefit to women on admission in labour. The clinical significance of the difference in women having Gram-negative bacteria is uncertain. Furthermore, the potential for side-effects suggests that shaving should not be part of routine clinical practice.</P>
<P>All three trials identified included the clipping of long hairs in their control groups to aid in operative procedures. This process is carried out for practical reasons, i.e. when performing instrumental deliveries or carrying out perineal repairs.<BR/>
</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2014-06-06 14:32:07 +0100" MODIFIED_BY="[Empty name]">
<P>It is unlikely that further randomised controlled trials on routine perineal shaving on admission in labour may provide additional information on maternal morbidity and perineal wound infections. In settings where midwives and doctors continue to perform routine perineal shaving, surveys on knowledge, attitude and behaviour of professionals could be useful to identify barriers and facilitators to change this practice.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-09-27 11:23:39 +0100" MODIFIED_BY="Sonja L Henderson">
<P>This Cochrane review updates the pre-Cochrane review undertaken by Prof Mary Renfrew in 1995 (<LINK REF="REF-Renfrew-1995" TYPE="REFERENCE">Renfrew 1995</LINK>).</P>
<P>We acknowledge Prof Zarko Alfirevic for his support and guidance and Dr Simona Di Mario for her support on the previous update of this review (<LINK REF="REF-Basevi-2000" TYPE="REFERENCE">Basevi 2000</LINK>).</P>
<P>We would like to thank Erika Ota for her support in the creation of the 'Summary of findings' table for this update. Erika Ota's work was financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization. The named authors alone are responsible for the views expressed in this publication.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2014-09-21 08:44:31 +0100" MODIFIED_BY="[Empty name]">
<P>Vittorio Basevi wrote the protocol and Tina Lavender commented. Tina Lavender and Vittorio Basevi wrote the review. Vittorio Basevi extracted the data and Tina Lavender checked the data.</P>
<P>Vittorio Basevi drafted the 2014 updated and Tina Lavender commented on drafts. </P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-09-27 11:18:43 +0100" MODIFIED_BY="Sonja L Henderson">
<P>The methods have been updated for the 2014 update and the quality of the evidence assessed using GRADE in order to assess the quality of the body of evidence relating to key outcomes. We added 'side-effects' as a non-prespecified outcome.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-10-23 11:37:13 +0100" MODIFIED_BY="Heather Maxwell">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnston-1922" NAME="Johnston 1922" YEAR="1922">
<REFERENCE NOTES="&lt;p&gt;Johnston RA, Sidail RS. Is the usual method of preparing patients for delivery beneficial or necessary? Am J Obstet Gynecol 1922. 4: 645-650.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnston RA, Sidall RS</AU>
<TI>Is the usual method of preparing patients for delivery beneficial or necessary?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1922</YR>
<VL>4</VL>
<PG>645-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kantor-1965" NAME="Kantor 1965" YEAR="1965">
<REFERENCE NOTES="&lt;p&gt;Kantor HI, Rember R, Tabio P, Buchanon R. Value of shaving the pudendal-perineal area in delivery preparation. , : 509-512.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kantor HI, Rember R, Tabio P, Buchanon R</AU>
<TI>Value of shaving the pudendal-perineal area in delivery preparation</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1965</YR>
<VL>25</VL>
<PG>509-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kovavisarach-2005" NAME="Kovavisarach 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kovavisarach E, Jirasettasiri P</AU>
<TI>Randomised controlled trial of perineal shaving versus hair cutting in parturients on admission in labor</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2005</YR>
<VL>88</VL>
<PG>1167-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-10-23 11:37:13 +0100" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_REFERENCES MODIFIED="2014-10-23 11:35:19 +0100" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Altaweli-2014" MODIFIED="2014-08-14 11:01:00 +0100" MODIFIED_BY="[Empty name]" NAME="Altaweli 2014" TYPE="JOURNAL_ARTICLE">
<AU>Altaweli RF, McCourt C, Baron M</AU>
<TI>Childbirth care practices in public sector facilities in Jeddah, Saudi Arabia: a descriptive study</TI>
<SO>Midwifery</SO>
<YR>2014</YR>
<VL>30</VL>
<NO>7</NO>
<PG>899-909</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Briggs-1997" MODIFIED="2008-02-15 16:36:10 +0000" MODIFIED_BY="Sonja Henderson" NAME="Briggs 1997" TYPE="JOURNAL_ARTICLE">
<AU>Briggs M</AU>
<TI>Principles of closed surgical wound care</TI>
<SO>Journal of Wound Care</SO>
<YR>1997</YR>
<VL>6</VL>
<NO>6</NO>
<PG>288-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Charrier-2010" MODIFIED="2014-09-23 15:03:34 +0100" MODIFIED_BY="[Empty name]" NAME="Charrier 2010" TYPE="JOURNAL_ARTICLE">
<AU>Charrier L, Serafini P, Chiono V, Rebora M, Rabacchi G, Zotti CM</AU>
<TI>Clean and sterile delivery: two different approaches to infection control</TI>
<SO>Journal of Evaluation in Clinical Practice</SO>
<YR>2010</YR>
<VL>16</VL>
<NO>4</NO>
<PG>771-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chen-2006" MODIFIED="2014-09-23 15:03:55 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2006" TYPE="JOURNAL_ARTICLE">
<AU>Chen CY, Wang KG</AU>
<TI>Are routine interventions necessary in normal birth?</TI>
<SO>Taiwan Journal of Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>45</VL>
<NO>4</NO>
<PG>302-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colomar-2004" MODIFIED="2014-09-23 15:04:19 +0100" MODIFIED_BY="[Empty name]" NAME="Colomar 2004" TYPE="JOURNAL_ARTICLE">
<AU>Colomar M, Belizán M, Cafferata ML, Labandera A, Tomasso G, Althabe F, et al</AU>
<TI>Practices of maternal and perinatal care performed in public hospitals of Uruguay</TI>
<TO>Prácticas en la atención maternal y perinatal realizadas en los hospitals públicos de Uruguay</TO>
<SO>Ginecologia y Obstetricia de Mexico</SO>
<YR>2004</YR>
<VL>72</VL>
<PG>455-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conde_x002d_Agudelo-2008" MODIFIED="2014-09-23 15:04:41 +0100" MODIFIED_BY="[Empty name]" NAME="Conde-Agudelo 2008" TYPE="JOURNAL_ARTICLE">
<AU>Conde-Agudelo A, Rosas-Bermudez A, Gülmezoglu AM</AU>
<TI>Evidence-based intrapartum care in Cali, Colombia: a quantitative and qualitative study</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>12</NO>
<PG>1547-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-d_x0027_Orsi-2005" MODIFIED="2014-09-23 15:06:34 +0100" MODIFIED_BY="[Empty name]" NAME="d'Orsi 2005" TYPE="JOURNAL_ARTICLE">
<AU>d'Orsi E, Chor D, Giffin K, Angulo-Tuesta A, Barbosa GP, Gama Ade S, et al</AU>
<TI>Quality of birth care in maternity hospitals of Rio de Janeiro, Brazil</TI>
<TO>Qualidade da atenção ao parto em maternidades do Rio de Janeiro</TO>
<SO>Revista de Saúde Pública</SO>
<YR>2005</YR>
<VL>39</VL>
<NO>4</NO>
<PG>645-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DeMaria-2014" MODIFIED="2014-09-23 15:06:53 +0100" MODIFIED_BY="[Empty name]" NAME="DeMaria 2014" TYPE="JOURNAL_ARTICLE">
<AU>DeMaria AL, Flores M, Hirth JM, Berenson AB</AU>
<TI>Complications related to pubic hair removal</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2014</YR>
<VL>210</VL>
<NO>6</NO>
<PG>528.e1-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GRADE-2008" MODIFIED="2014-09-21 09:13:26 +0100" MODIFIED_BY="[Empty name]" NAME="GRADE 2008" TYPE="COMPUTER_PROGRAM">
<AU>Brozek J, Oxman A, Schünemann H</AU>
<TI>GRADEpro</TI>
<YR>2008</YR>
<EN>3.6</EN>
<PB>The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2014-06-06 14:14:51 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nagpal-2014" MODIFIED="2014-10-14 23:46:17 +0100" MODIFIED_BY="Lynn Hampaon" NAME="Nagpal 2014" TYPE="OTHER">
<AU>Nagpal J, Sachdeva A, Sengupta Dhar R, Bhargava VL, Bhartia A</AU>
<TI>Widespread non-adherence to evidence-based maternity care guidelines: a population-based cluster randomised household survey</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2014 Aug 22 [Epub ahead of print]</YR>
<IDENTIFIERS MODIFIED="2014-08-29 07:47:08 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-08-29 07:47:08 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/1471-0528.13054"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Oakley-1979" MODIFIED="2014-09-23 15:07:29 +0100" MODIFIED_BY="[Empty name]" NAME="Oakley 1979" TYPE="BOOK">
<AU>Oakley A</AU>
<SO>Becoming A Mother</SO>
<YR>1979</YR>
<PB>Martin Robertson</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Qian-2001" MODIFIED="2014-08-14 11:31:56 +0100" MODIFIED_BY="[Empty name]" NAME="Qian 2001" TYPE="JOURNAL_ARTICLE">
<AU>Qian X, Smith H, Zhou L, Liang J, Garner P</AU>
<TI>Evidence-based obstetrics in four hospitals in China: An observational study to explore clinical practice, women's preferences and provider's views</TI>
<SO>BMC Pregnancy Childbirth</SO>
<YR>2001</YR>
<VL>1</VL>
<NO>1</NO>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-06-23 12:04:11 +0100" MODIFIED_BY="Leanne V Jones" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Romney-1980" MODIFIED="2014-09-11 11:11:05 +0100" MODIFIED_BY="[Empty name]" NAME="Romney 1980" TYPE="JOURNAL_ARTICLE">
<AU>Romney ML</AU>
<TI>Pre-delivery shaving: an unjustified assault?</TI>
<SO>Journal of Obstetrics and Gynaecology</SO>
<YR>1980</YR>
<VL>1</VL>
<PG>33-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schunemann-2009" MODIFIED="2014-08-14 11:32:32 +0100" MODIFIED_BY="Leanne V Jones" NAME="Schunemann 2009" TYPE="JOURNAL_ARTICLE">
<AU>Schunemann HJ</AU>
<TI>GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice</TI>
<TO>GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen</TO>
<SO>Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen</SO>
<YR>2009</YR>
<VL>103</VL>
<NO>6</NO>
<PG>391-400</PG>
<IDENTIFIERS MODIFIED="2014-08-14 11:32:32 +0100" MODIFIED_BY="Leanne V Jones"/>
</REFERENCE>
<REFERENCE ID="REF-SEA_x002d_ORCHID-2011" MODIFIED="2014-10-23 11:35:19 +0100" MODIFIED_BY="Heather Maxwell" NAME="SEA-ORCHID 2011" TYPE="JOURNAL_ARTICLE">
<AU>SEA-ORCHID Study Group, Lumbiganon P, McDonald SJ, Laopaiboon M, Turner T, Green S, Crowther CA</AU>
<TI>Impact of increasing capacity for generating and using research on maternal and perinatal health practices in South East Asia (SEA-ORCHID Project)</TI>
<SO>PLoS One</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>9</NO>
<PG>e23994</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sweidan-2008" MODIFIED="2014-09-23 15:08:10 +0100" MODIFIED_BY="[Empty name]" NAME="Sweidan 2008" TYPE="JOURNAL_ARTICLE">
<AU>Sweidan M, Mahfoud Z, DeJong J</AU>
<TI>Hospital policies and practices concerning normal childbirth in Jordan</TI>
<SO>Studies in Family Planning</SO>
<YR>2008</YR>
<VL>39</VL>
<NO>1</NO>
<PG>59-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tanner-2011" MODIFIED="2014-08-14 11:01:29 +0100" MODIFIED_BY="[Empty name]" NAME="Tanner 2011" TYPE="COCHRANE_REVIEW">
<AU>Tanner J, Norrie P, Melen K</AU>
<TI>Preoperative hair removal to reduce surgical site infection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>11</NO>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD004122.pub4"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-10-23 11:37:13 +0100" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Basevi-2000" MODIFIED="2014-10-23 11:37:13 +0100" MODIFIED_BY="Heather Maxwell" NAME="Basevi 2000" TYPE="COCHRANE_REVIEW">
<AU>Basevi V, Lavender T</AU>
<TI>Routine perineal shaving on admission in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2014-09-21 09:20:57 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-09-21 09:20:57 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001236"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Renfrew-1995" MODIFIED="2014-09-11 11:11:08 +0100" MODIFIED_BY="[Empty name]" NAME="Renfrew 1995" TYPE="OTHER">
<AU>Renfrew MJ</AU>
<TI>Routine perineal shaving on admission in labour. [revised 02 April 1992]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration: Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-10-24 13:14:46 +0100" MODIFIED_BY="Heather Maxwell">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-10-24 13:14:46 +0100" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2014-06-06 14:33:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Johnston-1922">
<CHAR_METHODS>
<P>Alternate allocation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-06 14:33:10 +0100" MODIFIED_BY="[Empty name]">
<P>389 women in labour.<BR/>Exclusions criteria: caesarean section; previously identified infection; eclampsia; postpartum admissions.</P>
<P>USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-06 14:33:21 +0100" MODIFIED_BY="[Empty name]">
<P>Pubic shaving plus the usual skin preparation (scrubbing of the external genitalia and inner thighs with green soap and water and the pouring of sterile water, alcohol and a weak solution of bichloride of mercury over the vulva and adjoining area) (N = 196) versus clipping of long pubic hairs only (no skin preparation) (N = 193).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Febrile puerperia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-06-06 14:33:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kantor-1965">
<CHAR_METHODS>
<P>Method of allocation not specified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-06 14:33:25 +0100" MODIFIED_BY="[Empty name]">
<P>150 labouring women pre delivery.</P>
<P>USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-06 14:33:41 +0100" MODIFIED_BY="[Empty name]">
<P>First comparison: shaving of the pudendal and perineal areas (N = 50) versus clipping of long pubic hairs (N = 50). In all women the pudendal and perineal region was washed with a diluted pHisoHex solution.<BR/>Second comparison: shaving of the pudendal and perineal areas (N = 25) versus clipping of long pubic hairs (N = 25). All women received povidone-iodine spray as skin preparation, after washing to remove pHisoHex.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Positive bacteriology cultures (gram positive and negative).<BR/>Maternal pyrexia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-09-23 15:00:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kovavisarach-2005">
<CHAR_METHODS>
<P>Random allocation from a table of random numbers with sequentially numbered, sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-09-23 15:00:46 +0100" MODIFIED_BY="[Empty name]">
<P>500 pregnant women recruited from 1 hospital. 42 women excluded after randomisation due to caesarean section.<BR/>Study period: November 2001-February 2002.<BR/>Inclusion criteria: term pregnancy (gestational age 37-42 weeks) true labour pain, singleton, cephalic presentation, living fetus. Exclusion criteria: women with medical or obstetric complications (e.g. premature rupture of membranes, HIV positive, treatment with antibiotics within 7 days of admission, birth canal or anal infection).</P>
<P>Thailand.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-06-06 14:36:16 +0100" MODIFIED_BY="[Empty name]">
<P>Perineal shaving (N = 231) versus cutting of perineal hair, down to 0.5 cm above the skin (N = 227). In all women the perineal region was scrubbed with 4% chlorhexidine scrub and rinsed with savlon solution (1:100).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-06-06 14:34:25 +0100" MODIFIED_BY="[Empty name]">
<P>Perineal wound infection; puerperal morbidity; puerperal infection; neonatal infection; satisfaction of the patients, accoucheurs and perineorrhaphy operators.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-06 14:36:23 +0100" MODIFIED_BY="[Empty name]">
<P>All women were attended by nurses, externs and obstetrics-gynaecology residents.<BR/>The episiotomy wounds were repaired either by externs or residents under the supervision of the senior residents.<BR/>The satisfaction of parturients was evaluated immediately after perineal repair had finished.<BR/>The definition of puerperal infection was based on histopathological and not clinical criteria.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-10-24 13:14:46 +0100" MODIFIED_BY="Heather Maxwell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-09-23 15:01:18 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 14:59:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>Women alternately allocated to experimental or control group. No information on the timing of allocation, the personnel involved, or the number of exclusions during this process.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:00:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>Method for determining the randomisation sequence not mentioned; insufficient information about the sequence generation process.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:01:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Use of a published table of random sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2014-10-24 13:14:46 +0100" MODIFIED_BY="Heather Maxwell" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 14:59:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>No sufficient detail about allocation sequence concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-10-24 13:14:46 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>Insufficient detail about allocation sequence concealment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:01:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Use of sealed sequentially numbered envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-09-23 15:01:20 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-23 14:59:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>Blinding not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-23 15:00:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>Blinding not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-09-23 15:01:20 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Blinding not possible due to the nature of the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-09-23 15:01:21 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-09-23 14:59:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>No mention of blinding of outcome assessors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-09-23 15:00:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>No mention of blinding of outcome assessors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-09-23 15:01:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>No mention of blinding of outcome assessors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-09-23 15:01:21 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-23 14:59:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>Not possible to determine the completeness of data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-23 15:00:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>Not possible to determine the completeness of data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-09-23 15:01:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>No missing outcome data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2014-09-23 15:01:22 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 14:59:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>Insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:00:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>Insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:01:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Insufficient information to permit judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-09-23 15:01:23 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 14:59:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Johnston-1922">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:00:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kantor-1965">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-23 15:01:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2014-11-12 09:44:23 +0000" MODIFIED_BY="Sonja L Henderson">
<SOF_TABLE ID="SOF-01" MODIFIED="2014-11-12 09:44:23 +0000" MODIFIED_BY="Sonja L Henderson" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-08-20 11:40:41 +0100" MODIFIED_BY="Grade Profiler">routine perineal shaving before childbirth for women in labour</TITLE>
<TABLE COLS="7" ROWS="22">
<TR>
<TD COLSPAN="7">
<P>
<B>Routine perineal shaving before childbirth for women in labour</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Population:</B> Women in labour<BR/>
<B>Settings:</B> Hospitals in US (Baltimore, Dallas) and Thailand (Bangkok)<BR/>
<B>Intervention:</B> Routine perineal shaving before childbirth versus clipping of long pubic hairs or cutting of perineal hairs<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Routine perineal shaving before childbirth</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Postpartum maternal febrile morbidity</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 1.16 </B>
<BR/>(0.74 to 1.80)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>997<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>
<B>very low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>67 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>77 per 1000</B>
<BR/>(48 to 119)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>18 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>20 per 1000</B>
<BR/>(12 to 33)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>High</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>124 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>141 per 1000</B>
<BR/>(90 to 213)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Neonatal infection</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Not estimable</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>458<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>see comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>The outcome was reported with no events.</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>Wound infection</B>
</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>
<B>RR 1.47 </B>
<BR/>(0.80 to 2.70)</P>
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>458<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>70 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>103 per 1000</B>
<BR/>(57 to 180)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>70 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>103 per 1000</B>
<BR/>(56 to 179)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Maternal satisfaction</B>
<BR/>Scale from 1 to 5</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean maternal satisfaction in the control groups was<BR/>
<B>3.8 </B>(five degrees)<SUP>4</SUP>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean maternal satisfaction in the intervention groups was<BR/>
<B>0 higher</B>
<BR/>(0.13 lower to 0.13 higher)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>MD 0.00</B>
</P>
<P>(-0.13, 0.13)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>458<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; <B>MD: </B>mean difference</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Most studies contributing data had serious design limitations.<BR/>
<SUP>2</SUP> Wide confidence interval crossing the line of no effect.<BR/>
<SUP>3</SUP>The total cumulative study population is not very small (sample size 458) and the total number of events is 40, but the 95% confidence interval is very wide.<BR/>
<SUP>4</SUP>Likert scales on five degrees to measure a women's intensity of satisfaction (5, excellent; 4, good; 3, average; 2, fair; and 1, poor).<BR/>
<SUP>5</SUP>Wide confidence interval crossing the line of no effect and small sample size.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-11-07 16:09:18 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-11-07 16:09:18 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Perineal shaving versus no perineal shaving</NAME>
<DICH_OUTCOME CHI2="1.572647474643219" CI_END="1.7595797583005701" CI_START="0.7333259091156641" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1359337242626817" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.24540895733475812" LOG_CI_START="-0.1347029706880302" LOG_EFFECT_SIZE="0.05535299332336397" METHOD="MH" MODIFIED="2014-09-21 08:09:00 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4555164750354286" P_Q="1.0" P_Z="0.568114076498612" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="502" TOTAL_2="495" WEIGHT="99.99999999999999" Z="0.5708311965615314">
<NAME>Postpartum maternal febrile morbidity</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.144209092498991" CI_START="0.8039199666806602" EFFECT_SIZE="1.3129251700680271" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="24" LOG_CI_END="0.331267133301898" LOG_CI_START="-0.0947871847827028" LOG_EFFECT_SIZE="0.11823997425959763" ORDER="1" O_E="0.0" SE="0.2502664154457826" STUDY_ID="STD-Johnston-1922" TOTAL_1="196" TOTAL_2="193" VAR="0.06263327870008105" WEIGHT="72.80274580952822"/>
<DICH_DATA CI_END="2.8636264378978966" CI_START="0.22349283814749424" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.45691636330724616" LOG_CI_START="-0.650736389323359" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2014-09-08 09:48:09 +0100" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.6506407098647712" STUDY_ID="STD-Kantor-1965" TOTAL_1="75" TOTAL_2="75" VAR="0.4233333333333334" WEIGHT="15.051162903861858"/>
<DICH_DATA CI_END="2.6560795563183115" CI_START="0.09089221438477929" EFFECT_SIZE="0.49134199134199136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.42424107911186654" LOG_CI_START="-1.0414733158378722" LOG_EFFECT_SIZE="-0.3086161183630028" MODIFIED="2014-09-08 09:48:10 +0100" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.8609678909967452" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="231" TOTAL_2="227" VAR="0.7412657093273833" WEIGHT="12.14609128660992"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.3577383485732613" CI_END="1.1097260396032957" CI_START="0.7920029075952754" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="96" I2="70.21804869265914" I2_Q="64.60052720392896" ID="CMP-001.02" LOG_CI_END="0.045215776828370656" LOG_CI_START="-0.10127322402885777" LOG_EFFECT_SIZE="-0.028028723600243537" METHOD="MH" MODIFIED="2014-11-07 16:09:18 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.06688995508804974" P_Q="0.09281273137890167" P_Z="0.4532389768545956" Q="2.8249008276501484" RANDOM="NO" SCALE="10.0" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="150" TOTAL_2="150" WEIGHT="200.0" Z="0.7500261243865866">
<NAME>Colonisation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6382849606874594" CI_START="0.8160448850967918" DF="0" EFFECT_SIZE="1.15625" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="0.21438944448817468" LOG_CI_START="-0.08828595299399664" LOG_EFFECT_SIZE="0.06305174574708902" NO="1" P_CHI2="1.0" P_Z="0.4141692032351423" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="100.0" Z="0.816578762956446">
<NAME>Gram-positive</NAME>
<DICH_DATA CI_END="1.6382849606874594" CI_START="0.8160448850967918" EFFECT_SIZE="1.15625" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="32" LOG_CI_END="0.21438944448817468" LOG_CI_START="-0.08828595299399664" LOG_EFFECT_SIZE="0.06305174574708902" ORDER="4" O_E="0.0" SE="0.17779302674840866" STUDY_ID="STD-Kantor-1965" TOTAL_1="75" TOTAL_2="75" VAR="0.03161036036036036" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9849142255370796" CI_START="0.6962951674812434" DF="0" EFFECT_SIZE="0.828125" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="64" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-0.006601589804891962" LOG_CI_START="-0.15720661896130428" LOG_EFFECT_SIZE="-0.08190410438309813" NO="2" P_CHI2="1.0" P_Z="0.03302417173303175" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="100.0" Z="2.1317892991496645">
<NAME>Gram-negative</NAME>
<DICH_DATA CI_END="0.9849142255370795" CI_START="0.6962951674812434" EFFECT_SIZE="0.828125" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="64" LOG_CI_END="-0.006601589804892011" LOG_CI_START="-0.15720661896130428" LOG_EFFECT_SIZE="-0.08190410438309813" ORDER="5" O_E="0.0" SE="0.08846613963339427" STUDY_ID="STD-Kantor-1965" TOTAL_1="75" TOTAL_2="75" VAR="0.007826257861635212" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-12 11:35:15 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="231" TOTAL_2="227" WEIGHT="0.0" Z="0.0">
<NAME>Neonatal infection</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="1" O_E="0.0" SE="0.0" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="231" TOTAL_2="227" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.7005948334437004" CI_START="0.8045459263997059" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.474025974025974" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="16" I2="0.0" I2_Q="99.99999999999999" ID="CMP-001.04" LOG_CI_END="0.4314594324663728" LOG_CI_START="-0.09444915975305353" LOG_EFFECT_SIZE="0.16850513635665965" METHOD="MH" MODIFIED="2014-09-12 11:35:33 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.20912509137836666" Q="3.228975364934539E-32" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="231" TOTAL_2="227" WEIGHT="100.0" Z="1.2559749102987343">
<NAME>Wound infection</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.7005948334437" CI_START="0.804545926399706" EFFECT_SIZE="1.474025974025974" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="16" LOG_CI_END="0.43145943246637275" LOG_CI_START="-0.09444915975305346" LOG_EFFECT_SIZE="0.16850513635665965" ORDER="1" O_E="0.0" SE="0.3089213103592078" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="231" TOTAL_2="227" VAR="0.09543237599404998" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.999513395555193" CI_START="0.013414906337740121" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3275862068965517" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.9030635699853647" LOG_CI_START="-1.8724123552055816" LOG_EFFECT_SIZE="-0.48467439261010836" METHOD="MH" MODIFIED="2014-09-12 11:35:46 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.49364233709256333" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="231" TOTAL_2="227" WEIGHT="99.99999999999999" Z="0.6845271797335332">
<NAME>Wound dehiscence</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.999513395555193" CI_START="0.013414906337740121" EFFECT_SIZE="0.3275862068965517" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9030635699853647" LOG_CI_START="-1.8724123552055816" LOG_EFFECT_SIZE="-0.48467439261010836" ORDER="1" O_E="0.0" SE="1.6303282972845683" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="231" TOTAL_2="227" VAR="2.6579703569267994" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-12 11:36:16 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Need for wound resuturing</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-12 11:36:28 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Discomfort</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-12 11:36:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Pain</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-12 11:37:02 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal embarrassment</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2014-09-12 11:37:19 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal satisfaction</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.12822123378733552" CI_START="-0.12822123378733552" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2014-09-12 11:37:47 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="231" TOTAL_2="227" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>Maternal satisfaction continuous data</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.12822123378733552" CI_START="-0.12822123378733552" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="3.8" ORDER="1" SD_1="0.7" SD_2="0.7" SE="0.0654201989417807" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="231" TOTAL_2="227" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-10-24 13:14:47 +0100" MODIFIED_BY="Heather Maxwell">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-10-24 13:14:47 +0100" MODIFIED_BY="Heather Maxwell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-10-24 13:14:47 +0100" MODIFIED_BY="Heather Maxwell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVMAAAGvCAIAAABpeaFBAAAT/ElEQVR42u3dv24d1xHHcQIGghQs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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2014-10-24 13:18:40 +0100" MODIFIED_BY="Heather Maxwell">
<APPENDIX ID="APP-01" MODIFIED="2014-10-24 13:18:40 +0100" MODIFIED_BY="Heather Maxwell" NO="1">
<TITLE MODIFIED="2014-06-23 12:01:29 +0100" MODIFIED_BY="Leanne V Jones">Methods to be used in future updates</TITLE>
<APPENDIX_BODY MODIFIED="2014-10-24 13:18:40 +0100" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="3">Selection of studies</HEADING>
<P>Two review authors will independently assess for inclusion all the potential studies we identify as a result of the search strategy. We will resolve any disagreement through discussion or, if required, we will consult a third person.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data extraction and management</HEADING>
<P>We will design a form to extract data. For eligible studies, at least two review authors will extract the data using the agreed form. We will resolve discrepancies through discussion or, if required, we will consult a third person. We will enter data into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) and check for accuracy.</P>
<P>When information regarding any of the above is unclear, we will attempt to contact authors of the original reports to provide further details.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of risk of bias in included studies</HEADING>
<P>Two review authors will independently assess risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We will resolve any disagreement by discussion or by involving a third assessor.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We will describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We will assess the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We will describe for each included study the method used to conceal allocation to interventions prior to assignment and will assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We will assess the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We will describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We will consider that studies are at low risk of bias if they were blinded, or if we judge that the lack of blinding would be unlikely to affect results. We will assess blinding separately for different outcomes or classes of outcomes.</P>
<P>We will assess the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We will describe for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We will assess blinding separately for different outcomes or classes of outcomes.</P>
<P>We will assess methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We will describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We will state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information is reported, or can be supplied by the trial authors, we will re-include missing data in the analyses which we undertake.</P>
<P>We will assess methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We will describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We will assess the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We will describe for each included study any important concerns we have about other possible sources of bias.</P>
<P>We will assess whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We will make explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <I>Handbook </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we will assess the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings. We will explore the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
<P>We will assess the quality of the evidence using the GRADE approach in order to assess the quality of evidence related to the following key outcomes (maximum of seven) (<LINK REF="REF-Schunemann-2009" TYPE="REFERENCE">Schunemann 2009</LINK>).</P>
<OL>
<LI>Postpartum maternal febrile morbidity.</LI>
<LI>Neonatal infection.</LI>
<LI>Wound infection.</LI>
<LI>Maternal satisfaction (continuous data).</LI>
</OL>
<P>GRADE profiler (GRADE 2008) will be used to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create &#8217;Summary of findings&#8217; tables. A summary of the intervention effect and a measure of quality for each of the above outcomes will be produced using the GRADE approach to provide a measure of quality. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. For assessments of the overall quality of evidence for each outcome the evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of treatment effect</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Unit of analysis issues</HEADING>
<P>Cluster-randomised trials and cross-over trials will not be eligible for inclusion in this review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dealing with missing data</HEADING>
<P>For included studies, we will note levels of attrition. We will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<P>For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis, i.e. we will attempt to include all participants randomised to each group in the analyses, and all participants will be analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial will be the number randomised minus any participants whose outcomes are known to be missing.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of heterogeneity</HEADING>
<P>We will assess statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We will regard heterogeneity as substantial if the I² is greater than 30% and either the Tau² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test for heterogeneity. 
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of reporting biases</HEADING>
<P>If there are 10 or more studies in the meta-analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data synthesis</HEADING>
<P>We will carry out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We will use fixed-effect meta-analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials&#8217; populations and methods are judged sufficiently similar. If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random-effects meta-analysis to produce an overall summary if an average treatment effect across trials is considered clinically meaningful. The random-effects summary will be treated as the average of the range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials.</P>
<P>If we use random-effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I².</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis and investigation of heterogeneity</HEADING>
<P>If we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful, and if it is, use random-effects analysis to produce it.</P>
<P>We plan to carry out the following subgroup analyses for subsets of studies by:</P>
<OL>
<LI>random sequence generation and allocation concealment;</LI>
<LI>year of publication.</LI>
</OL>
<P>The following outcomes will be used in subgroup analysis:</P>
<UL>
<LI>postpartum maternal febrile morbidity, neonatal infection, maternal satisfaction.</LI>
</UL>
<P>We will assess subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis</HEADING>
<P>We will conduct a sensitivity analysis to explore the impact of attrition in trials, with poor quality studies with high levels of missing data being excluded from the analysis.</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>